Handelsbanken Fonder Ab Ptc Therapeutics, Inc. Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 24,700 shares of PTCT stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,700

Previous 22,200 11.26%

Holding current value

$1.12 Million

Previous $679,000 34.9%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$30.39 - $37.66 $75,975 - $94,149	2,500 Added 11.26%	24,700 $916,000
Q2 2024 Aug 05, 2024	SELL	$24.69 - $40.12 $125,919 - $204,612	-5,100 Reduced 18.68%	22,200 $679,000
Q1 2024 May 13, 2024	BUY	$24.15 - $31.95 $255,989 - $338,670	10,600 Added 63.47%	27,300 $794,000
Q4 2023 Feb 01, 2024	BUY	$18.07 - $29.37 $61,438 - $99,858	3,400 Added 25.56%	16,700 $460,000
Q3 2023 Oct 19, 2023	SELL	$22.41 - $41.99 $3.14 Million - $5.88 Million	-140,000 Reduced 91.32%	13,300 $298,000
Q2 2023 Aug 02, 2023	SELL	$40.4 - $59.1 $1.56 Million - $2.29 Million	-38,700 Reduced 20.16%	153,300 $6.24 Million
Q1 2023 Apr 28, 2023	SELL	$38.16 - $48.86 $1.6 Million - $2.05 Million	-42,000 Reduced 17.95%	192,000 $9.3 Million
Q4 2022 Feb 07, 2023	SELL	$33.53 - $54.79 $9.1 Million - $14.9 Million	-271,400 Reduced 53.7%	234,000 $8.93 Million
Q3 2022 Oct 27, 2022	SELL	$41.85 - $53.85 $627,750 - $807,750	-15,000 Reduced 2.88%	505,400 $25.4 Million
Q2 2022 Aug 03, 2022	BUY	$25.6 - $45.23 $3.62 Million - $6.4 Million	141,400 Added 37.31%	520,400 $20.8 Million
Q1 2022 May 11, 2022	BUY	$33.33 - $44.6 $196,647 - $263,140	5,900 Added 1.58%	379,000 $14.1 Million
Q3 2021 Nov 10, 2021	BUY	$37.01 - $44.74 $37,010 - $44,740	1,000 Added 0.27%	373,100 $13.9 Million
Q2 2021 Aug 03, 2021	BUY	$37.95 - $49.37 $49,335 - $64,181	1,300 Added 0.35%	372,100 $15.7 Million
Q1 2021 Apr 29, 2021	BUY	$46.8 - $68.92 $234,000 - $344,600	5,000 Added 1.37%	370,800 $17.6 Million
Q4 2020 Feb 11, 2021	SELL	$47.96 - $67.64 $527,560 - $744,040	-11,000 Reduced 2.92%	365,800 $22.3 Million
Q3 2020 Nov 13, 2020	BUY	$45.41 - $57.07 $1.14 Million - $1.43 Million	25,000 Added 7.11%	376,800 $17.6 Million
Q2 2020 Aug 13, 2020	BUY	$42.56 - $54.98 $1.27 Million - $1.64 Million	29,800 Added 9.25%	351,800 $17.9 Million
Q1 2020 May 14, 2020	SELL	$32.37 - $59.36 $1.97 Million - $3.62 Million	-61,000 Reduced 15.93%	322,000 $14.4 Million
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $1.93 Million - $3 Million	60,000 Added 18.58%	383,000 $18.4 Million
Q3 2019 Oct 31, 2019	BUY	$33.82 - $48.17 $1.79 Million - $2.55 Million	53,000 Added 19.63%	323,000 $10.9 Million
Q2 2019 Jul 12, 2019	BUY	$35.42 - $45.0 $9.56 Million - $12.2 Million	270,000 New	270,000 $12.2 Million

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.24B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Ptc Therapeutics, Inc. Transaction History